Pawel Bialik, MS

Principal Investigator
Gene Editing Institute ChristianaCare, United States

Presentation(s):

• P25: CRISPR Directed Gene Editing of NRF2 in Squamous Lung Cancer (A Novel Approach to Overcoming Drug Resistance)

  Thursday, March 21, 2024
  9:48am – 9:55am ET